Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.65 Insider Own15.32% Shs Outstand27.79M Perf Week11.05%
Market Cap212.32M Forward P/E- EPS next Y-0.22 Insider Trans1.28% Shs Float23.53M Perf Month0.92%
Income-49.79M PEG- EPS next Q-0.36 Inst Own30.25% Short Float4.68% Perf Quarter78.50%
Sales4.61M P/S46.06 EPS this Y56.39% Inst Trans-1.30% Short Ratio4.09 Perf Half Y139.50%
Book/sh0.57 P/B13.29 EPS next Y83.00% ROA-149.30% Short Interest1.10M Perf Year21.46%
Cash/sh0.98 P/C7.81 EPS next 5Y15.00% ROE-500.09% 52W Range2.25 - 8.50 Perf YTD83.65%
Dividend Est.- P/FCF- EPS past 5Y64.26% ROI-318.43% 52W High-10.12% Beta0.63
Dividend TTM- Quick Ratio2.25 Sales past 5Y3.79% Gross Margin64.90% 52W Low239.56% ATR (14)0.48
Dividend Ex-Date- Current Ratio2.52 EPS Y/Y TTM29.17% Oper. Margin-871.17% RSI (14)62.45 Volatility7.02% 6.67%
Employees76 Debt/Eq0.58 Sales Y/Y TTM56.75% Profit Margin-1080.72% Recom1.00 Target Price21.20
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q42.36% Payout- Rel Volume3.89 Prev Close7.73
Sales Surprise41.64% EPS Surprise0.88% Sales Q/Q425.80% EarningsMay 14 BMO Avg Volume269.33K Price7.64
SMA205.56% SMA5023.33% SMA20070.32% Trades Volume1,047,924 Change-1.16%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Stephens Overweight $25
Jul-26-22Resumed Canaccord Genuity Buy $17
Dec-10-21Initiated H.C. Wainwright Buy $25
Mar-09-21Initiated Canaccord Genuity Buy $24
Jan-05-21Initiated BTIG Research Buy $23
Jun-01-20Initiated Laidlaw Buy $19
Jun-14-24 08:50AM
Jun-03-24 09:55AM
May-28-24 09:30AM
May-17-24 09:55AM
May-15-24 08:50AM
03:02AM Loading…
May-14-24 11:52AM
May-07-24 08:30AM
May-06-24 09:00AM
May-03-24 05:15PM
Apr-23-24 09:55AM
Apr-05-24 09:55AM
Apr-04-24 08:35AM
Apr-02-24 12:00PM
11:50AM Loading…
Mar-27-24 11:50AM
Mar-26-24 11:52AM
Mar-22-24 02:43PM
Mar-20-24 08:15AM
Mar-19-24 09:00AM
Mar-18-24 05:20PM
Mar-15-24 08:20AM
Mar-08-24 05:00PM
Feb-22-24 05:00PM
Feb-16-24 05:00PM
Jan-31-24 08:00AM
08:00AM Loading…
Jan-23-24 08:00AM
Jan-16-24 08:00AM
Jan-12-24 05:00PM
Dec-15-23 01:02PM
Dec-07-23 09:00AM
Nov-15-23 05:00PM
Nov-13-23 04:05PM
Nov-06-23 04:30PM
Oct-16-23 08:30AM
Oct-10-23 08:30AM
Oct-03-23 08:30AM
Sep-27-23 04:05PM
Sep-14-23 09:59AM
Sep-11-23 08:00AM
Sep-05-23 04:00PM
Sep-01-23 02:07PM
Aug-29-23 08:00AM
Aug-14-23 09:10PM
Aug-12-23 09:02AM
Aug-09-23 05:33PM
Aug-03-23 08:30AM
Jun-21-23 04:10PM
Jun-20-23 08:30AM
Jun-07-23 04:10PM
May-12-23 08:00AM
May-09-23 09:00AM
May-03-23 08:30AM
Apr-03-23 04:30PM
Mar-29-23 09:41PM
Mar-27-23 03:15PM
Feb-16-23 08:30AM
Feb-14-23 08:49AM
Jan-30-23 08:30AM
Jan-17-23 08:00AM
Dec-16-22 04:15PM
Dec-13-22 08:30AM
Dec-08-22 08:30AM
Dec-05-22 09:00AM
Nov-09-22 04:15PM
Nov-08-22 08:00AM
Oct-24-22 04:05PM
Sep-01-22 04:15PM
Aug-08-22 07:45AM
Aug-05-22 08:30AM
Jul-27-22 04:30PM
Jul-20-22 04:10PM
Jul-18-22 08:30AM
Jun-07-22 07:06AM
Jun-06-22 04:15PM
May-10-22 07:30AM
May-09-22 08:30AM
May-02-22 03:02PM
Apr-28-22 09:00AM
Apr-08-22 09:00AM
Mar-29-22 09:00AM
Mar-25-22 07:30AM
Mar-15-22 04:30PM
Mar-10-22 09:00AM
Mar-02-22 04:01PM
Feb-22-22 09:00AM
Feb-10-22 04:30PM
Feb-07-22 04:01PM
Feb-04-22 09:00AM
Feb-03-22 04:30PM
Jan-25-22 04:01PM
Jan-07-22 09:00AM
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aharon GilDirectorMar 19 '24Buy3.7226,882100,0011,069,710Mar 20 08:00 PM
SALAMON STEVEN A JDirectorMar 19 '24Buy3.7226,882100,0011,121,025Mar 20 07:44 PM
Vukovic VojoChief Medical OfficerDec 12 '23Buy3.0040,000120,000100,000Dec 14 04:20 PM
MICHEL GERARD JChief Executive OfficerDec 08 '23Buy2.9434,00099,960262,345Dec 11 05:02 PM
Rosalind Advisors, Inc.DirectorNov 17 '23Buy2.40100,000240,4101,038,828Nov 21 11:07 AM
Pennell SandraSVP of Finance, PFO and PAONov 17 '23Buy2.4330,00072,90030,000Nov 21 07:42 AM
Vukovic VojoChief Medical OfficerNov 16 '23Buy2.4860,000148,80060,000Nov 20 04:22 PM
Hoffman David L.See RemarksNov 16 '23Buy2.4840,00099,20040,000Nov 20 04:20 PM
Purpura JohnChief Operating OfficerOct 13 '23Buy3.4414,50549,89741,526Oct 17 04:53 PM
Sylvester John RichardDirectorAug 21 '23Buy4.8010,55050,64010,550Aug 23 11:03 AM